Drug ID: | NPD5729 |
Drug Name: | |
Molecular Formula: | C23H32N4O8 |
Canonical SMILES: | O=C[C@@H](N=C([C@@H](N=C([C@H](C(C)C)N=C([C@@H](N=C(O)C)Cc1ccc(cc1)O)O)O)C)O)CC(=O)O |
Standard InCHI: | InChI=1S/C23H32N4O8/c1-12(2)20(23(35)24-13(3)21(33)26-16(11-28)10-19(31)32)27-22(34)18(25-14(4)29)9-15-5-7-17(30)8-6-15/h5-8,11-13,16,18,20,30H,9-10H2,1-4H3,(H,24,35)(H,25,29)(H,26,33)(H,27,34)(H,31,32)/t13-,16-,18-,20-/m0/s1 |
Standard InCHIKey: | LPIARALSGDVZEP-SJVNDZIOSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7